Dr. Eneman - Dr. Deraeve SRL
Dr. Eneman - Dr. Deraeve reported total assets of 82,022 € at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Jun 2026).
The score of Dr. Eneman - Dr. Deraeve shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -91 % Total assets -32 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Eneman - Dr. Deraeve's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Jun 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 25 Jun 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 27 Jun 2022
Dr. Eneman - Dr. Deraeve's financial analysis
- Solvency10.1%sector median: 72.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Eneman - Dr. Deraeve
Dr. Eneman - Dr. Deraeve's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0758.552.173
- VAT number
- BE0758552173
- Peppol
- Registered · 0208:0758552173 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Nov 2020
- Registered office
- 3001 Leuven
- Latest accounts
- 2025 · filed on 17 Jun 2026
- Activity
- General medical practice activities (NACE 86210)
Dr. Eneman - Dr. Deraeve (SRL) has been based in Leuven since 2020, active in: general medical practice activities. For 2025, it reports a net profit of 93,315 € and equity of 8,264 €; its revenue is not published. Its solvency stands at 10.1%, below the median of its sector (72.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Eneman - Dr. Deraeve
Companies in the same business, of comparable size and area, outside its group.
- Dokter Simon Leclercq General medical practice activities Leuven · balance sheet 56,625 €
- Curans General medical practice activities Leuven · balance sheet 62,060 €
- Licéno General medical practice activities Leuven · balance sheet 39,735 €
- Dr. Tuur Helsen General medical practice activities Leuven · balance sheet 227,022 €
- Fisiotics Medical specialists activities Kampenhout · balance sheet 68,124 €
- Sofie Odent Medical specialists activities Herent · balance sheet 145,819 €
- Dr. Wouter L’Hoyes Medical specialists activities Herent · balance sheet 40,455 €
- Docinside Medical specialists activities Lubbeek · balance sheet 174,270 €
Frequently asked questions about Dr. Eneman - Dr. Deraeve
What is the revenue of Dr. Eneman - Dr. Deraeve?
Dr. Eneman - Dr. Deraeve files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Eneman - Dr. Deraeve?
In Belgium, the VAT number is the company number prefixed with BE: BE0758552173 for Dr. Eneman - Dr. Deraeve, if the company is VAT-registered. Its company number (CBE) is 0758.552.173.
Where is the registered office of Dr. Eneman - Dr. Deraeve?
According to the CBE register, the registered office of Dr. Eneman - Dr. Deraeve is in 3001 Leuven.
What is the equity of Dr. Eneman - Dr. Deraeve?
At the close of the 2025 financial year, the equity of Dr. Eneman - Dr. Deraeve amounts to 8,264 €, a solvency of 10.1% of total assets.
Who manages Dr. Eneman - Dr. Deraeve?
The register lists 2 active mandates at Dr. Eneman - Dr. Deraeve. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Eneman - Dr. Deraeve
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →